Abstract:Pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are ligand-activated transcription factors that regulate the expression of drug metabolizing enzymes and drug transporters. Since their discoveries, they have been studied as important factors for regulating processes related to drug efficacy, drug toxicity, and drug-drug interactions. However, their vast ligand-binding profiles extend into additional spaces, such as endogenously produced chemicals, microbiome metabolites, dietary compounds, and environmental pollutants. Therefore, PXR and CAR can respond to an enormous abundance of stimuli, resulting in significant shifts in metabolic programs and physiologic homeostasis. Naturally, PXR and CAR have been implicated in various diseases related to homeostatic perturbations, such as inflammatory bowel disorders, diabetes, and certain cancers. Recent findings have injected the field with new signaling mechanisms and tools to dissect the complex PXR and CAR biology and have strengthened the potential for future PXR and CAR modulators in the clinic. Here, we describe the historical and ongoing importance of PXR and CAR in drug metabolism pathways and how this history has evolved into new mechanisms that regulate and are regulated by these xenobiotic receptors, with a specific focus on small molecule ligands. To effectively convey the impact of newly emerging research, we have arranged five diverse and representative key recent advances, four specific challenges, and four perspectives on future directions. SIGNIFICANCE STATEMENT PXR and CAR are key transcription factors that regulate homeostatic detoxification of the liver and intestines. Diverse chemicals bind to these nuclear receptors, triggering their transcriptional tuning of the cellular metabolic response. This minireview revisits the importance of PXR and CAR in pharmaceutical drug responses and highlights recent results with implications beyond drug metabolism.

Advances in regulation of pregnane X receptor-mediated drug transporter

The transcriptional regulation of drug enzymes and transporters mediated by Pregnane X receptor and its significant role in multidrug resistance

Function of pregnane X receptor in drug mechanism and research progress

Advances in Search for Pregnane X Receptor

Regulation of Pregnane X Receptor(PXR)by Herbal Medicines

Regulation of PXR in drug metabolism: chemical and structural perspectives

Role of pregnane X receptor in chemotherapeutic treatment

Regulation of drug resistance by human pregnane X receptor in breast cancer.

Progresses of researches on the correlation between pregnane X receptor and CYP3A

Dietary phytochemicals as modulators of human pregnane X receptor

Regulation of Pxr and Car by Protein-Protein Interaction and Signaling Crosstalk

Advances in the Research of Pregnane X Receptor and Constitutive Androstane Receptor

Pregnane X Receptor As the “sensor and Effector” in Regulating Epigenome

Pregnane X receptor as the "sensor and effector" in regulating epigenome.

Regulation of Drug-Metabolizing Enzymes by Xenobiotic Receptors: PXR and CAR

Research Progress on Drug Transport Associated with P-glycoprotein and MDR1 Gene

The role of pregnane X receptor (PXR) in substance metabolism

Biology of Pxr: Role in Drug-Hormone Interactions

Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond

Effects of Genetics Variants of Pregnant Xenobiotic Receptor and on Pharmacogenetics and Drug Metabolism

Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study.